Pay-for-Delay Lawsuit Against Teva, AbbVie Gets Go-Ahead in Pennsylvania

Drug Industry Daily
A A
A federal court in Pennsylvania ruled that a class-action lawsuit by drug distributors against Teva and AbbVie over pay-for-delay allegations can continue.

To View This Article:

Login

Subscribe To Drug Industry Daily